TABLE 3.
Summary of biochemical findings in CD patients from clinical reports using sodium pyruvate as a treatment.
| Patient age (years) | NaPy dose (g/day)/duration (days) | Biochemical findings a | |||
|---|---|---|---|---|---|
| Improved but not normalized | Normalized | Unchanged | Worsened | ||
| Mutoh et al. 37 (Phenotype: AACD) | |||||
| 13 | 6/1095 | T/S | TG, PSTI | T. bil, AST, ALT, Amy, T. chol, HDL‐C, BUN, UA, NH3, TP, Lac, Pyr, Na+, Cit, Ala, FR | Arg, Gln |
| Yazaki et al. 34 (Phenotype: AACD) | |||||
| 34 | 3–15/77 | Exact values not provided (results in graph format) | |||
| 41 | 3/23 | ||||
| Yazaki et al. 58 (Phenotype: AACD) | |||||
| 72 | 3–9/121 | ALB, Arg, FR | RBC, Hb, TP, T. chol, ALP, GGT, Amy, PSTI | WBC, PLT, Cr, TG, ALT, LDH, T. bil, prothrombin time, activated partial prothromboplasmin time, NH3 | BUN, AST, Cit |
| Kogure et al. 44 (Phenotype: AACD) | |||||
| 68 | 4.5–8/1825 | Cit | NH3, PSTI | ||
| Nagasaka et al. 45 (Phenotype: silent period) b | |||||
| 3–13 | 300 c /91–182 | Carn | Citr, ICitr, ɑ‐KG, ACarn, BHB, FFA, FBG, HbA1c, Lac, Pyr, L/P | Suc, Fum, Mal, FI | |
Abbreviations: α‐KG, alpha‐ketoglutarate; AACD, adolescent and adult citrin deficiency (formerly CTLN2); ACarn, acetylcarnitine; Ala, alanine; ALB, albumin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; Amy, amylase; Arg, arginine; aPTT, activated partial thromboplastin time; ASS, argininosuccinate synthetase; AST, aspartate aminotransferase; BHB, β‐hydroxybutyrate; BUN, blood urea nitrogen; Carn, carnitine; CD, citrin deficiency; ChE, cholinesterase; Citr, citrate; Cit, citrulline; Cr, creatinine; D. bil, direct bilirubin; FBG, fasting blood glucose; Fe, iron; FFA, free fatty acids; FI, fasting insulin: FIB, fibrinogen; FR, fischer ratio; Fum, fumarate; Gln, glutamine; GGT, gamma‐glutamyl transpeptidase; Glu, glutamate; GS, glutamine synthetase; HE, hpatic encephalopathy; Hb, hemoglobin; HbA1c, hemoglobin A1c; HDL‐C, high‐density lipoprotein cholesterol; HYA, hyaluronic acid; ICitr, isocitrate; L/P, lactate to pyruvate ratio; Lac, lactate; LDH, lactate dehydrogenase; Mal, malate; MCT, medium chain triglycerides; Met, methionine; Na+, sodium ions; NaPy, sodium pyruvate; NICCD, neonatal intrahepatic cholestasis caused by citrin deficiency; NH3, ammonia; OGTT, oral glucose tolerance test; PSTI, pancreatic secretory trypsin inhibitor; PLT, platelet count; Pyr, pyruvate; RBC, red blood cell count; Suc, succinate; T/S, threonine to serine ratio; TG, triglycerides; T. bil, total bilirubin; T. chol, total cholesterol; TBA, total bile acid; TCA, tricarboxylic acid; Thr, threonine; TIBC, total iron‐binding capacity; TP, total protein; Tyr, tyrosine; UA, uric acid; WBC, white blood cell count.
Based on reference ranges provided in citations.
Reference ranges not provided. Data are compared against control values obtained from healthy volunteers.
Units in mg/kg/day.